Standardized procedure, quality control and efficacy evaluation of laparoscopic surgery for colorectal cancer

doi:10.16139/j.1007-9610.2024.03.01

Abstract

Abstract:

The safety and efficacy of laparoscopic surgery for colorectal cancer has been confirmed by several large-scale clinical studies. Laparoscopy has become the main modality of surgical treatment for colorectal cancer in China. Based on evidence-based medicine and the experience accumulated in clinical practice, laparoscopic colorectal surgical techniques are still being continuously optimised and improved. The key techniques mainly revolve around the following three aspects:①complete surgical excision extension;②appropriate lymph node dissection area;③safe digestive tract reconstruction. Prioritizing the standardization of laparoscopic colorectal cancer surgery, promoting the consistent implementation of these procedures, establishing a scientific evaluation system, thoroughly assessing surgical outcomes, and conducting high-quality clinical research are essential for enhancing the standardization of laparoscopic colorectal cancer surgery in China.

Key words: Laparoscopic surgery, Colorectal cancer, Surgical procedure, Standardization, Quality control

CLC Number:

YAO Hongwei, WEI Pengyu, GAO Jiale, ZHANG Zhongtao. Standardized procedure, quality control and efficacy evaluation of laparoscopic surgery for colorectal cancer[J]. Journal of Surgery Concepts & Practice, 2024, 29(03): 187-191.

References 30

[1]	SUNG H, FERALY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
[2]	VELDKAMP R, KUHRY E, HOP W C, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial[J]. Lancet Oncol, 2005, 6(7):477-484.
[3]	COLON CANCER LAPAROSCOPIC OR OPEN RESECTION STUDY GROUP; BUUNEN M, VELDKAMP R, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial[J]. Lancet Oncol, 2009, 10(1):44-52.
[4]	FLESHMAN J, BRANDA M, SARGENT D J, et al. Effect of laparoscopic-assisted resection vs. open resection of stage Ⅱ or Ⅲ rectal cancer on pathologic outcomes:the ACOSOG Z6051 randomized clinical trial[J]. JAMA, 2015, 314(13):1346-1355.
[5]	STEVENSON A R, SOLOMON M J, LUMLEY J W, et al. Effect of laparoscopic-assisted resection vs. open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial[J]. JAMA, 2015, 314(13):1356-1363.
[6]	KANG S B, PARK J W, JEONG S Y, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial[J]. Lancet Oncol, 2010, 11(7):637-645.
[7]	BONJER H J, DEIJEN C L, ABIS G A, et al. A rando-mized trial of laparoscopic versus open surgery for rectal cancer[J]. N Engl J Med, 2015, 372(14):1324-1332.
[8]	PENNA M, HOMPES R, ARNOLD S, et al. Transanal total mesorectal excision:international registry results of the first 720 cases[J]. Ann Surg, 2017, 266(1):111-117.
[9]	LACY A M, TASENDE M M, DELGADO S, et al. Tran-sanal total mesorectal excision for rectal cancer: outcomes after 140 patients[J]. J Am Coll Surg, 2015, 221(2):415-423.
[10]	HEALD R J, RYALL R D. Recurrence and survival after total mesorectal excision for rectal cancer[J]. Lancet, 1986, 1(8496):1479-1482. doi: 10.1016/s0140-6736(86)91510-2 pmid: 2425199
[11]	ROODBEEN S X, DE LACY F B, VAN DIEREN S, et al. Predictive factors and risk model for positive circumfe-rential resection margin rate after transanal total mesorectal excision in 2653 patients with rectal cancer[J]. Ann Surg, 2019, 270(5):884-891.
[12]	BATTERSBY N J, HOW P, MORAN B, et al. Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY Ⅱ study[J]. Ann Surg, 2016, 263(4):751-760.
[13]	中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020, 58(8):561-585.
	National Health Commission of the People's Republic of China. [Chinese protocol of diagnosis and treatment of colorectal cancer (2020 edition)][J]. Chin J Surg, 2020, 58(8):561-585. doi: 10.3760/cma.j.cn112139-20200518-00390 pmid: 32727186
[14]	HOHENBERGER W, WEBER K, MATZEL K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome[J]. Colorectal Dis, 2009, 11(4):354-364.
[15]	XU L, SU X, HE Z, et al. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superio-rity trial[J]. Lancet Oncol, 2021, 22(3):391-401.
[16]	HASHIGUCHI Y, HASE K, UENO H, et al. Optimal margins and lymphadenectomy in colonic cancer surgery[J]. Br J Surg, 2011, 98(8):1171-1178. doi: 10.1002/bjs.7518 pmid: 21560120
[17]	TOMITA N, ISHIDA H, TANAKAYA K, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer[J]. Int J Clin Oncol, 2021, 26(8):1353-1419.
[18]	中华人民共和国国家卫生健康委员会,中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2023年版)[J]. 中华外科杂志, 2023, 61(8):617-644.
	National Health Commission of the People′s Republic of China, Chinese Society of Oncology. [Chinese protocol of diagnosis and treatment of colorectal cancer (2023 edition)][J]. Chin J Surg, 2023, 61(8):617-644. doi: 10.3760/cma.j.cn112139-20230603-00222 pmid: 37400205
[19]	MATSUDA K, YOKOYAMA S, HOTTA T, et al. Oncological outcomes following rectal cancer surgery with high or low ligation of the inferior mesenteric artery[J]. Gastrointest Tumors, 2017, 4(1-2):45-52.
[20]	KANEMITSU Y, HIRAI T, KOMORI K, et al. Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery[J]. Br J Surg, 2006, 93(5):609-615.
[21]	KIM D J, CHUNG J J, YU J S, et al. Evaluation of lateral pelvic nodes in patients with advanced rectal cancer[J]. AJR Am J Roentgenol, 2014, 202(6):1245-1255.
[22]	GAO J, GU X, PANG M, et al. Risk factors for anastomotic leak and postoperative morbidity after right hemicolectomy for colon cancer: results from a prospective, multi-centre, snapshot study in China[J]. Br J Surg, 2024, 11(1):znad316.
[23]	ZHONG H, CAI Z, LU J, et al. Pathological and peri-operative outcomes of extracorporeal versus intracorporeal anastomosis in laparoscopic transverse colon cancer resection: retrospective multicentre study[J]. BJS Open, 2023, 7(3),zrad045.
[24]	王楠, 郑波波, 吴涛, 等. 全腹腔镜左半结肠癌根治术Overlap法消化道重建的应用[J]. 中华胃肠外科杂志, 2018, 21(3):299-304.
	WANG N, ZHENG B B, WU T, et al. [Application of overlap method to digestive tract reconstruction of totally laparoscopic left colectomy][J]. Chin J Gastrointest Surg, 2018, 21(3):299-304.
[25]	PARC Y, RUPPERT R, FUERST A, et al. Better function with a colonic J-pouch or a side-to-end anastomosis?: a randomized controlled trial to compare the complications, functional outcome, and quality of life in patients with low rectal cancer after a J-pouch or a side-to-end anastomosis[J]. Ann Surg, 2019, 269(5):815-826. doi: 10.1097/SLA.0000000000003249 pmid: 30921049
[26]	OKKABAZ N, HAKSAL M, ATICI A E, et al. J-pouch vs. side-to-end anastomosis after hand-assisted laparoscopic low anterior resection for rectal cancer: a prospective randomized trial on short and long term outcomes including life quality and functiona l results[J]. Int J Surg, 2017, 47:4-12.
[27]	RYBAKOV E G, PIKUNOV D Y, FOMENKO O Y, et al. Side-to-end vs. straight stapled colorectal anastomosis after low ante rior resection: results of randomized clinical trial[J]. Int J Colorectal Dis, 2016, 31(8):1419-1426.
[28]	侯森, 刘凡, 叶颖江. 直肠癌低位前切除术中不同肠道重建方式对术后功能保护的研究进展[J]. 中华胃肠外科杂志, 2021, 24(4):372-376.
	HOU S, LIU F, YE Y J. [Research progress of different bowel reconstructions for postoperative functional protection during low anterior resections of rectal cancer][J]. Chin J Gastrointest Surg, 2021, 24(4):372-376.
[29]	TSAI A Y, MAVROVELL S, MISKOVIC D, et al. Surgical quality assurance in COLOR Ⅲ: standardization and competency assessment in a randomized controlled trial[J]. Ann Surg, 2019, 270(5):768-774.
[30]	YAO H, AN Y, ZHANG H, et al. Transanal total mesorectal excision: short-term outcomes of 1283 cases from a nationwide registry in China[J]. Dis Colon Rectum, 2021, 64(2):190-199. doi: 10.1097/DCR.0000000000001820 pmid: 33395134